Togami, K., Pastika, T., Stephansky, J., Ghandi, M., Christie, A. L., Jones, K. L., . . . Lane, A. A. (2019). DNA methyltransferase inhibition overcomes diphthamide pathway deficiencies underlying CD123-targeted treatment resistance. The Journal of clinical investigation, 129(11), 5005-5019. https://doi.org/10.1172/JCI128571
Citácia podle Chicago (17th ed.)Togami, Katsuhiro, et al. "DNA Methyltransferase Inhibition Overcomes Diphthamide Pathway Deficiencies Underlying CD123-targeted Treatment Resistance." The Journal of Clinical Investigation 129, no. 11 (2019): 5005-5019. https://doi.org/10.1172/JCI128571.
Citácia podľa MLA (8th ed.)Togami, Katsuhiro, et al. "DNA Methyltransferase Inhibition Overcomes Diphthamide Pathway Deficiencies Underlying CD123-targeted Treatment Resistance." The Journal of Clinical Investigation, vol. 129, no. 11, 2019, pp. 5005-5019, https://doi.org/10.1172/JCI128571.